Kapruvia

*
Pharmacy Only: Prescription
  • Company:

    Vifor Pharma UK Limited
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to restricted prescription (C)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Updated on 24 October 2022

File name

Kapruvia IE PIL July 2022.pdf

Reasons for updating

  • Correction of spelling/typing errors

Updated on 24 October 2022

File name

Kapruvia_IE SPC_July 2022.pdf

Reasons for updating

  • Correction of spelling/typing errors

Legal category:Product subject to restricted prescription (C)

Updated on 09 August 2022

File name

Kapruvia IE SPC July 2022.pdf

Reasons for updating

  • Change to section 10 - Date of revision of the text
  • Correction of spelling/typing errors

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

Type IB C.I.z variation: Correction of typos + editorial changes

Updated on 09 August 2022

File name

Kapruvia IE PIL July 2022.pdf

Reasons for updating

  • Change to improve clarity and readability
  • Change to date of revision

Updated on 16 May 2022

File name

Kapruvia_IE SPC_May 2022.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 10 May 2022

File name

kapruvia IE PIL May 2022.pdf

Reasons for updating

  • New PIL for new product

Free text change information supplied by the pharmaceutical company

New Irish PIL for recently approved product.

Updated on 10 May 2022

File name

Kapruvia_IE SPC_May 2022.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

New Irish SPC of recently approved product.